Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Imfinzi cancer combo falls short in DANUBE trial

pharmatimesMarch 09, 2020

Tag: Imfinzi , Bladder cancer , AstraZeneca , tremelimumab

PharmaSources Customer Service